Remove 2011 Remove Biotechnology Remove Development Remove Engineering
article thumbnail

Developing Global Leaders Is America's Competitive Advantage

Harvard Business Review

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. American companies and academic institutions possess unique competitive advantages in developing these global leaders.

article thumbnail

Technology Progresses When Business, Government, and Academia Work Together

Harvard Business Review

The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011. The Joint Center For Energy Storage Research (JCESR) has a five-year mandate to develop next generation battery technologies. The Era of Big Science. Innovating the Innovation Process. Killing Ideas Faster.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

India Remakes Global Innovation

Harvard Business Review

In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. and the U.K.

article thumbnail

It's Manufacturing's Turn for Special Treatment

Harvard Business Review

And one look at the trade deficit ($558 billion in 2011) clearly indicates we don't have as much as our foreign competitors to sell in return. Indian companies, for instance, are already doing quite well exporting services like software development, technical support, and back-office processing to America. The Right Policies.

article thumbnail

The Industries Plagued by the Most Uncertainty

Harvard Business Review

For example, a wide variety of clean technologies (including wind, solar, and hydrogen) are vying to power vehicles and cities at the same time that a wide variety of medical technologies (chemical, biotechnological, genomic, and robotic) are being developed to treat diseases. Consider the 2×2 matrix below.